Clearside Biomedical to Present Research on Proprietary Retinal Therapeutics Platform at 2013 Association for Research in Vision & Ophthalmology Meeting
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Clearside Biomedical, Inc., a privately held ophthalmic company developing and commercializing targeted therapeutics for the treatment of sight-threatening diseases, today announced that research on its proprietary retinal therapeutics platform will be presented at the 2013 Annual Meeting of the Association for Research and Vision in Ophthalmology (ARVO), May 5-9, 2013, in Seattle, WA.
Help employers find you! Check out all the jobs and post your resume.
Clearside Biomedical, Inc., a privately held ophthalmic company developing and commercializing targeted therapeutics for the treatment of sight-threatening diseases, today announced that research on its proprietary retinal therapeutics platform will be presented at the 2013 Annual Meeting of the Association for Research and Vision in Ophthalmology (ARVO), May 5-9, 2013, in Seattle, WA.
Help employers find you! Check out all the jobs and post your resume.